Author

Marie Colin

Observed name: M Colin

Observed institutions: Institute of Physics, University of Amsterdam

ORCID: 0009-0005-2395-6114

Observed ORCID: 0009-0005-2395-6114

OpenAlex ID: A5032230986

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39

Incidence, prevalence and clinical presentation of inflammatory bowel diseases in Northern France: a 30-year population-based study

2024 · Hélène Sarter, Thibaut Crétin, et al. · The Lancet Regional Health - Europe · 31

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12

Prophylactic Proton Pump Inhibitors in Upper Gastrointestinal Bleeding: Impact and Underprescription in a French Multicentric Cohort

2024 · Weam El Hajj, Stéphane Nahon, et al. · Digestive Diseases and Sciences · 3

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases

Plasma-Assisted Air Cleaning Decreases COVID-19 Infections in a Primary School: Modelling and Experimental Data

2024 · Tika van Bennekum, Marie Colin, et al. · Lecture notes in computer science

Works count: 7

Citation count: 125

H-index: 4

I10-index: 4